.png)
Collaborations Pharmaceuticals, Inc., North Carolina, United States
Sean is founder and CEO of Collaborations Pharmaceuticals, Inc. which is focused on developing and using machine learning and AI approaches for rare and neglected disease drug discovery. Sean graduated from the University of Aberdeen; receiving his M.Sc., Ph.D. in Clinical Pharmacology and D.Sc. in Science. He was a postdoc at Eli Lilly then senior scientist at Pfizer, then served at increasing levels of responsibility in several start-up pharma and software companies (Concurrent, GeneGo, CDD and Phoenix Nest) as well as scientific advisor for several rare disease foundations (PHRF, HNF). He has authored or co-authored >360 peer reviewed papers, book chapters, edited 5 books on different aspects of drug discovery research as well as authored a new book on ‘Winning Grants’. His interests include the dual use of AI and coverage of his research has also appeared in the Economist, Financial Times, Washington Post and appears in a Netflix documentary “Unknown: Killer Robots”.
Disclosure information not submitted.
Applying Artificial Intelligence in a Small Drug Discovery Company
Tuesday, February 6, 2024
11:30 AM – 12:00 PM EST